Key Takeaway
Patient guide to GLP-1 medications for diabetes management. Learn how these treatments work, what to expect, and how to get the best results from your therapy.
Executive Summary
GLP-1 receptor agonists are a class of prescription medications that have transformed diabetes management over the past decade. These drugs work by mimicking a natural hormone your body produces after eating, helping your pancreas release the right amount of insulin at the right time. For people with type 2 diabetes, GLP-1 medications typically lower HbA1c by 1.0 to 2.0 percentage points, promote weight loss of 5 to 15 pounds or more, and reduce the risk of heart attack and stroke. This guide explains what you need to know as a patient considering or currently using GLP-1 therapy for diabetes.
What the Clinical Evidence Means for You
How Well Do These Medications Work?
Clinical trials involving thousands of patients have consistently shown that GLP-1 medications are among the most effective treatments available for type 2 diabetes. Here is what the numbers look like in practical terms:
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
- Blood sugar control: In the SUSTAIN trials, patients taking semaglutide (brand names Ozempic and Wegovy) saw their HbA1c drop by an average of 1.5 to 1.8 percentage points. If your HbA1c is currently 8.5%, this could bring it down to the 6.7 to 7.0% range
- Weight loss: Most patients lose weight on GLP-1 medications. In clinical trials, average weight loss with semaglutide ranged from 10 to 14 pounds over 6 to 12 months. Some patients lose more, some less. The newer medication tirzepatide (Mounjaro/Zepbound) showed even greater weight loss in trials
- Heart protection: The LEADER trial showed that liraglutide reduced the risk of heart attack, stroke, or cardiovascular death by 13%. The SUSTAIN-6 trial[1] showed a 26% reduction with semaglutide
- Kidney protection: The FLOW trial found that semaglutide reduced the risk of serious kidney problems by 24% in patients with diabetes and existing kidney disease
What These Numbers Mean in Everyday Life
An HbA1c reduction of 1.5 percentage points is substantial. It can mean the difference between being told your diabetes is "uncontrolled" and reaching your target. It translates to lower average blood sugars throughout your day, fewer spikes after meals, and reduced long-term risk of complications affecting your eyes, kidneys, nerves, and blood vessels .
Weight loss of even 5 to 7% of your body weight has been shown to improve how your body responds to insulin, lower blood pressure, and improve cholesterol levels. For a 200-pound person, that's 10 to 14 pounds, which is within the range most patients achieve with GLP-1 therapy .
How Do GLP-1 Medications Compare to Other Diabetes Treatments?
In head-to-head studies, GLP-1 medications have outperformed several other diabetes drug classes:
- Semaglutide lowered HbA1c more effectively than insulin glargine (a long-acting insulin), while also causing weight loss instead of weight gain
- Semaglutide produced greater HbA1c reduction and weight loss than sitagliptin (Januvia), a DPP-4 inhibitor
- Tirzepatide lowered HbA1c more than semaglutide in the SURPASS-2 trial[2], with greater weight loss as well
How GLP-1 Medications Work in Your Body
When you eat food, your gut releases a hormone called GLP-1 (glucagon-like peptide-1). This hormone does several things simultaneously:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Tells your pancreas to release insulin: But only when your blood sugar is actually improved. This is an important distinction from some other diabetes medications, because it means the risk of your blood sugar dropping too low (hypoglycemia) is minimal
- Reduces glucagon: Glucagon is another hormone that tells your liver to release stored sugar into your blood. When glucagon is inappropriately high (which is common in type 2 diabetes), your liver keeps dumping sugar into your bloodstream even when you don't need it. GLP-1 medications help correct this
- Slows stomach emptying: Food moves through your stomach more slowly, which means sugar from your meal enters your bloodstream more gradually. This smooths out the blood sugar spikes that often follow meals
- Reduces appetite: GLP-1 receptors in your brain help regulate hunger and fullness signals. Patients commonly report feeling satisfied sooner during meals and having less interest in snacking between meals
The natural GLP-1 your body makes is broken down within minutes. GLP-1 medications are engineered to last much longer, which is why they can be given once weekly (injections like Ozempic and Mounjaro) or once daily (oral semaglutide/Rybelsus) .
Tirzepatide (Mounjaro/Zepbound) works on two hormone receptors instead of one. In addition to GLP-1, it also activates the GIP (glucose-dependent insulinotropic polypeptide) receptor. This dual action may explain why it produces somewhat larger improvements in blood sugar and weight compared to GLP-1-only medications .
Safety Profile: What to Watch For
Common Side Effects
The most common side effects are digestive in nature. Here is what the clinical trials tell us about how often they occur:
- Nausea: Affects roughly 15 to 20% of patients. Usually worst during the first few weeks and when the dose increases. Most patients find it manageable and it improves with time
- Vomiting: Reported by about 5 to 10% of patients
- Diarrhea: Occurs in about 8 to 15% of patients
- Constipation: Affects approximately 5 to 10% of patients
- Decreased appetite: This is technically a side effect but is often welcome for patients trying to manage their weight
These digestive side effects are the main reason your provider starts you on a low dose and increases it gradually over several weeks. Eating smaller meals, avoiding very fatty or rich foods, and staying hydrated can also help .
Low Blood Sugar Risk
When used alone or with metformin, GLP-1 medications carry a very low risk of hypoglycemia (low blood sugar). This is because they only stimulate insulin release when your blood sugar is improved. But if you're also taking a sulfonylurea (such as glipizide or glimepiride) or insulin, the risk of low blood sugar increases, and your provider may need to reduce the dose of those other medications .
Serious but Uncommon Risks
- Pancreatitis: Inflammation of the pancreas has been reported rarely. If you experience severe, persistent abdominal pain (especially if it radiates to your back), contact your provider or seek emergency care immediately
- Gallbladder problems: Weight loss of any kind can increase the risk of gallstones. Tell your provider if you develop pain in the upper right side of your abdomen
- Thyroid tumors: In animal studies (rodents specifically), GLP-1 medications caused thyroid tumors. This hasn't been confirmed in humans, and human thyroid tissue has far fewer GLP-1 receptors than rodent thyroid tissue. But these medications aren't recommended for anyone with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome
Who Should Not Take GLP-1 Medications
GLP-1 medications aren't appropriate if you:
- Have a personal or family history of medullary thyroid cancer
- Have Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- Are allergic to the medication or its components
- Are pregnant, planning to become pregnant, or breastfeeding
- Have type 1 diabetes (these medications are for type 2 diabetes)
Always share your complete medical history with your provider before starting any new medication .
Practical Guide: Getting the Most From Your Treatment
Available GLP-1 Medications
Several GLP-1-based medications are currently available for type 2 diabetes:
- Semaglutide injection (Ozempic): Once-weekly injection, available in 0.25 mg, 0.5 mg, 1 mg, and 2 mg doses
- Oral semaglutide (Rybelsus): Daily tablet taken on an empty stomach with a small sip of water, available in 3 mg, 7 mg, and 14 mg
- Liraglutide (Victoza): Daily injection, available in 0.6 mg, 1.2 mg, and 1.8 mg doses
- Dulaglutide (Trulicity): Once-weekly injection, available in 0.75 mg, 1.5 mg, 3 mg, and 4.5 mg
- Tirzepatide (Mounjaro): Once-weekly injection, available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg
What to Expect When Starting
Here is a general timeline of what most patients experience:
- Weeks 1-4: You start at the lowest dose. Some nausea may occur. You may notice a reduced appetite early on. Blood sugar improvements can begin within the first week
- Weeks 4-12: Your dose is gradually increased. Digestive side effects, if any, tend to improve. Blood sugar readings and HbA1c begin to show meaningful improvement
- Months 3-6: You reach your maintenance dose. Weight loss becomes more noticeable. HbA1c reductions typically reach their full effect around 3 to 6 months
- Months 6-12 and beyond: Benefits continue to accumulate. Weight loss may continue gradually. Cardiovascular and kidney protection builds over time
Tips for Success
- Be patient with side effects: Nausea and other GI symptoms usually improve within a few weeks. Don't skip doses because of mild nausea
- Eat mindfully: Many patients find that eating slowly, choosing smaller portions, and limiting greasy foods helps reduce digestive discomfort
- Stay hydrated: Drink plenty of water, especially if you experience vomiting or diarrhea
- Keep your injection schedule consistent: For weekly injections, choose the same day each week. You can change the day if needed, as long as there are at least 2 days between doses
- Combine with lifestyle changes: GLP-1 medications work best alongside a balanced diet and regular physical activity. Even moderate exercise like a 30-minute daily walk can amplify the benefits
- Monitor your blood sugar: Continue checking your blood sugar as directed by your provider, especially during dose adjustments
- Communicate with your provider: Report any new or persistent side effects. Your dose or medication can be adjusted if needed
Storage and Administration
Injectable GLP-1 medications need to be stored in the refrigerator (36 to 46 degrees F) before first use. Once in use, most pens can be kept at room temperature (up to 86 degrees F) for a specified number of days (typically 28 to 56 days, depending on the medication). Don't freeze. Inject into your abdomen, thigh, or upper arm, rotating injection sites each time .
Frequently Asked Questions
Will I need to take insulin if I start a GLP-1 medication?
Not necessarily. Many patients who start GLP-1 therapy find that it provides enough blood sugar control to avoid or delay insulin. In clinical trials, semaglutide lowered HbA1c more effectively than insulin glargine while causing weight loss instead of weight gain . But some patients with more advanced diabetes may still benefit from combining a GLP-1 medication with insulin. Your provider will help determine the right approach for your situation.
How long will I need to take a GLP-1 medication?
Type 2 diabetes is a chronic condition, and most patients benefit from ongoing treatment. Research has shown that when GLP-1 medications are stopped, blood sugar levels and weight tend to return toward their pre-treatment levels . Many patients use these medications long-term, but your provider will regularly assess whether your treatment plan needs adjustment.
Can I take a GLP-1 medication if I have kidney problems?
Yes, GLP-1 medications are generally safe for patients with kidney disease and don't require dose adjustments based on kidney function. In fact, the FLOW trial demonstrated that semaglutide actually protects the kidneys in patients with diabetes and chronic kidney disease . But patients with severe kidney impairment should be monitored closely for GI side effects, which can lead to dehydration and worsen kidney function .
What if I miss a dose?
If you miss a weekly injection and it has been less than 5 days since the missed dose, take it as soon as you remember. If more than 5 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Don't double up on doses. Missing an occasional dose is unlikely to significantly affect your overall blood sugar control .
Are GLP-1 medications safe to use with my other diabetes medications?
GLP-1 medications are commonly used alongside metformin, SGLT2 inhibitors (like empagliflozin or dapagliflozin), and insulin. When combined with sulfonylureas or insulin, your provider may reduce the dose of those medications to prevent low blood sugar. Don't combine two different GLP-1 medications (for example, don't take Ozempic and Trulicity together) .
Medical References
- Marso SP, Daniels GH, Tanaka K, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311-322. [PubMed | ClinicalTrials.gov | DOI]
- Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. [PubMed | DOI]
Take the Next Step
If you have type 2 diabetes and want to find out whether a GLP-1 medication could help you reach your health goals, our physician-supervised telehealth platform makes it easy to connect with a licensed provider. Your consultation will include a personalized evaluation of your medical history, current medications, and treatment options. Start today.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →